Sang Hak Han

机构：Hallym University, Sacred Heart Hospital, Hallym University Chuncheon Sacred Heart Hospital

发表论文 56 篇 · 总被引 1581 次 · h-index 18

代表论文

• Gut microbiota-derived indole compounds attenuate metabolic dysfunction-associated steatotic liver disease by improving fat metabolism and inflammation (2024 · Gut Microbes · 被引 158)
• Lactobacillus lactis and Pediococcus pentosaceus ‐driven reprogramming of gut microbiome and metabolome ameliorates the progression of non‐alcoholic fatty liver disease (2021 · Clinical and Translational Medicine · 被引 143)
• Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis (2020 · Clinical and Molecular Hepatology · 被引 135)
• Akkermansia muciniphila improve cognitive dysfunction by regulating BDNF and serotonin pathway in gut-liver-brain axis (2024 · Microbiome · 被引 91)
• Bifidobacterium-derived short-chain fatty acids and indole compounds attenuate nonalcoholic fatty liver disease by modulating gut-liver axis (2023 · Frontiers in Microbiology · 被引 88)
• Characteristics of microbiome-derived metabolomics according to the progression of alcoholic liver disease (2023 · Hepatology International · 被引 48)